1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,587 | 0,592 | 11:43 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | Theraclion Initiates Its Commercial Momentum in the First Half of 2026 | 388 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 15.07. | Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL | 342 | Business Wire | Regulatory News:
Theraclion (Paris:ALTHE):
Listing venue: Euronext Growth Paris
PEA-PME eligible
ISIN Code: FR0010120402
Website: www.theraclion.com
Under the liquidity contract entrusted... ► Artikel lesen | |
| 09.07. | Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors | 387 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 02.07. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 337 | Business Wire | Article 223-16 Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 18.06. | Theraclion Announces the Evolution of Its Board of Directors | 838 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 08.06. | Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code | 388 | Business Wire | Regulatory News:
Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment... ► Artikel lesen | |
| 04.06. | Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China | 427 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the... ► Artikel lesen | |
| 03.06. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 364 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 01.06. | Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented | 394 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse
Theraclion... ► Artikel lesen | |
| 11.05. | Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase | 422 | Business Wire | Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million
Regulatory News:
This press release and the information it contains... ► Artikel lesen | |
| 28.04. | Theraclion's non-invasive varicose treatment poised for FDA decision | 2 | The Armchair Trader | ||
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026 | 503 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026
Aktien
1 ID1000132806 PT Multi Bintang Indonesia... ► Artikel lesen | |
| 20.04. | Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription... | 756 | Business Wire | Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical... ► Artikel lesen | |
| 16.04. | Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook | 603 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.01. | Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up | 479 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 09.12.25 | Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements | 708 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.10.25 | Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results | 596 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 21.10.25 | Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China | 443 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 10.10.25 | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 511 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Place de cotation: Euronext Growth Paris
Éligible PEA PME
Code ISIN:... ► Artikel lesen | |
| 24.09.25 | Theraclion: Sonovein Receives MDR Certification, Strengthening Its Commercial Potential | 474 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 27,060 | -2,59 % | EQS-Adhoc: Gerresheimer AG: Gerresheimer veräußert Centor und das globale Primary Packaging Plastics Geschäft an Apax Fonds | EQS-Ad-hoc: Gerresheimer AG / Schlagwort(e): Mergers und Acquisitions / Verkauf von Unternehmensteilen/Strategische Unternehmensentscheidung
Gerresheimer veräußert Centor und das globale... ► Artikel lesen | |
| MCKESSON | 715,40 | -0,42 % | McKesson's Compounding Keeps Adding Up | ||
| INMODE | 13,155 | -1,35 % | InMode Ltd. - 6-K, Report of foreign issuer | ||
| HCA HEALTHCARE | 353,70 | 0,00 % | HCA Healthcare, Inc. - 10-Q, Quarterly Report | ||
| LIMES SCHLOSSKLINIKEN | 570,00 | +3,64 % | EQS-DD: Limes Schlosskliniken AG: GMF Capital GmbH, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
02.07.2026 / 10:04... ► Artikel lesen | |
| BEYOND AIR | 6,280 | -0,79 % | Beyond Air Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules | GARDEN CITY, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 20,400 | 0,00 % | HEALTHCARE SERVICES GROUP INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| ADDUS HOMECARE | 100,00 | 0,00 % | Addus HomeCare Non-GAAP EPS of $1.73 beats by $0.03, revenue of $377.4M beats by $1.18M | ||
| INTERPACE BIOSCIENCES | 1,310 | -1,50 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces First Quarter 2026 Financial and Business Results | Q1 Revenue of $9.0 millionQ1 Income from Continuing Operations of $0.8 millionQ1 Thyroid volume year-over-year increase of 10%Q1 Thyroid revenue year-over-year increase of 12% PARSIPPANY, NJ, May... ► Artikel lesen | |
| MODERN DENTAL | 0,875 | +2,34 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.06.2026 | Das Instrument 7V3 SE0006371126 CANTARGIA AB EQUITY wird ex Kapitalmassnahme gehandelt am 03.06.2026 The instrument 7V3 SE0006371126 CANTARGIA AB EQUITY is traded ex capital adjustment on 03.06.2026Das... ► Artikel lesen | |
| IVF HARTMANN | 133,00 | +0,38 % | Dividendenbekanntmachungen (16.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ANTOFAGASTA PLC GB0000456144 0,48 USD 0,4068 EUR APETIT OYJ FI0009003503 - 0,7 EUR ARBUTHNOT BANKING GROUP PLC GB0007922338 0,31... ► Artikel lesen | |
| MYOMO | 0,866 | -4,63 % | MYOMO, INC. - 8-K, Current Report | ||
| ICU MEDICAL | 148,00 | -1,99 % | Biotech Stocks At 52-Week Highs - ANIK & CHE Rise With Q2 Results, ICUI, NBIX, RPRX | LONDON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 29, 2026, driven by key catalysts such as the release of second quarter financial results and ongoing clinical... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,47 | +0,01 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,515 | -7,46 % | Aktien Frankfurt Ausblick: Dax-Rekord bleibt im Blick - Ölpreisrückgang hilft | FRANKFURT (dpa-AFX) - Die weiter nachgebenden Energiepreise dürften dem Dax auch am zweiten Börsentag der Woche Auftrieb geben. An seine Vortagesgewinne dürfte der deutsche Leitindex somit am Dienstag... ► Artikel lesen |
Das Unternehmen THERACLION SA kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,031 (+5,58 %) liegt der Kurs bei 0,587 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION SA finden Sie auf Wallstreet Online.